Maternite Regionale et Universitaire de Nancy
Nancy, Meurthe-et-moselle, 54000, France
NCT Number: NCT05696223
When a FGR is diagnose, the challenge in his monitoring is to assess the benefit-risk balance between continuing the pregnancy in order to limit complications related to prematurity and birth in order to minimize any risk of fetal death in utero. By able to know the characteristics of fetal deteriorations and its relationship with fetal and neonatal outcomes could be a thankful help in this decision. The placental insufficiency is by far the most common cause of FGR (32)(miller 2008). This effect can be documented thanks to ultrasound examinations to study fetal growth and Doppler of umbilical arteries for the placenta, the middle cerebral artery for the brain perfusion and the Ductus Venosus for the cardiac effects of placental dysfunction. The apparition of Doppler abnormalities suggests a deterioration of the disease and leads to several changes in clinical FGR management. Nevertheless, at this time, very few studies allow us to predict the time util the degradation and their impact on perinatal outcomes.
The primary aim of this study was to evaluate the performance of the Doppler at the time of diagnosis in predicting the outcome of pregnancies. The secondary aim was to evaluate the performance of Doppler performed at any time during pregnancy and studied independently in predicting outcome of pregnancies
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Nancy, Meurthe-et-moselle, 54000, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Doppler mesure
Time frame: during pregnancy (6 month per patient maximum)
Time frame: during pregnancy (6 month per patient maximum)
Central Hospital, Nancy, France
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05774236
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Barcelona, Spain
View Trial DetailsNCT05576207
Anemia of Pregnancy, Birth Weight
Rangpur City, Bangladesh
View Trial DetailsNCT06039319
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Knoxville, Tennessee, United States
View Trial DetailsNCT04839185
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Madison, Wisconsin, United States
View Trial Details